Public tenders in Germany

260 open tenders

CountryTenderValueClosesDays left

Conclusion of non-exclusive agreements on medicinal products containing the active substance Ponesimod (ATC Code: L04AE04) via an open-house model

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 162615-2026

value not stated1 lot

Fri 30 Apr23:58 in Berlin

183days

Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Beclometasone/Formoterol (WHO ATC Code: R03AK08)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 176734-2026

value not stated1 lot

Mon 31 May23:58 in Berlin

214days

Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Tamsulosin/Dutasteride (WHO ATC Code: G04CA52)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 803445-2025

value not stated1 lot

Mon 31 May23:58 in Berlin

214days

Conclusion of non-exclusive pharmaceutical rebate agreements pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Apremilast (WHO ATC Code: L04AA32)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 811450-2025

value not stated1 lot

Mon 31 May23:59 in Berlin

214days

Non-exclusive drug rebate agreements concluded under § 130a Abs. 8 SGB V via an open-house model for the active substance Denosumab Prolia (WHO ATC code: M05BX04)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 451344-2026

value not stated1 lot

Mon 31 May23:59 in Berlin

214days

Conclusion of non-exclusive medicine discount agreements pursuant to § 130a paragraph 8 SGB V via an Open-House model for the active substance Formoterol/Aclidinium bromide (WHO ATC-code: R03AL05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 309969-2026

value not stated1 lot

Wed 30 Jun23:58 in Berlin

244days

Conclusion of non-exclusive medicine discount agreements pursuant to § 130a paragraph 8 SGB V via an Open-House model for the active substance Liraglutide (WHO ATC-code: A10BJ02; official ATC: A10BJ02)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 309108-2026

value not stated1 lot

Wed 30 Jun23:58 in Berlin

244days

Conclusion of non-exclusive agreements for medicines with the active substance Nintedanib (ATC-code: L01EX09), via an Open-House model

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 232797-2026

value not stated1 lot

Wed 30 Jun23:58 in Berlin

244days

Conclusion of non-exclusive drug discount agreements under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Nilotinib (WHO ATC code: L01EA03)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 308469-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

275days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for medicinal products containing the active substance Denosumab Xgeva (WHO ATC Code: M05BX04)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 464454-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

275days

Conclusion of non-exclusive drug discount agreements under § 130a, paragraph 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Ustekinumab (WHO ATC code: L04AC05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 343328-2026

value not stated1 lot

Sat 31 Jul23:58 in Berlin

275days

Pharmaceutical Discount Agreements pursuant to Section 130a para. 8 of the German Social Code Book V (SGB V) within the framework of open-house procedures

IKK classic, DresdenTED 702716-2025

value not stated25 lots

Sun 5 Sep23:59 in Berlin

311days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Ipratropium bromide (WHO ATC Code: R03BB01)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 478099-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of non-exclusive drug discount agreements under § 130a Abs. 8 SGB V via an Open-House model for the active substance Teduglutid (WHO ATC code: A16AX08)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 583104-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Epoetin alfa and Epoetin zeta (WHO ATC Code: B03XA01)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 236720-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Omalizumab (WHO ATC Code: R03DX05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 473851-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active substance Epinephrine (WHO ATC-code: C01CA24) in pre-filled syringe/pen

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 534781-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of a non-exclusive pharmaceutical rebate agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) via an open-house model for the active substance Atomoxetine, excluding the pharmaceutical form solution (WHO ATC Code: N06BA09)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 449660-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Conclusion of non-exclusive drug discount agreement pursuant to § 130a Abs. 8 SGB V via an Open-House model for the active substance Epinephrine (WHO ATC-code: C01CA24) in nasal spray form

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 535909-2026

value not stated1 lot

Thu 30 Sep23:58 in Berlin

336days

Non-exclusive Drug Discount Agreement under § 130a para. 8 SGB V via Open-House Model for the Active Substance Certolizumab pegol (WHO ATC Code: L04AB05)

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 617680-2026

value not stated1 lot

Sun 31 Oct23:58 in Berlin

367days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.